Labiana Pharmaceuticals S.L.U

Spain5 medicines2 countries

5 medicines in 2 countries, as authorisation holder, manufacturer and marketer.

Medicines

Every medicine in the registers under its name, current ones first.

5 medicines

Medicine	Substance	Country	Status	Authorised
FOSFOMICINA LABIANA 3 G GRANULADO PARA SOLUCION ORAL EN SOBRES EFG5,631 g · Granulado para solución oral	Fosfomycin	Spain	Marketed	2016
Octreotide Labiana 0,1 mg/ml oplossing voor injectie/infusieOplossing voor injectie, Oplossing voor infusie	Octreotide	Netherlands	Authorised	2026
Octreotide Labiana 0,5 mg/ml oplossing voor injectie/infusieOplossing voor injectie, Oplossing voor infusie	Octreotide	Netherlands	Authorised	2026
FOSFOMICINA LABIANA 2 G GRANULADO PARA SOLUCION ORAL EN SOBRES EFG		Spain	unknown	2016
FOSFOMICINA LABIANA PHARMA 2 G GRANULADO PARA SOLUCION ORAL EN SOBRES EFG		Spain	unknown	2017

Countries

Where it holds or makes medicines, with how many are current.

Country	Medicines	Current	Past

Know your medicines, with the sources.

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Join Prognia free

Spain	3	1	2	Companies All medicines
Netherlands	2	2	0	Companies All medicines

Sources and licences

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Agencia Española de Medicamentos y Productos Sanitarios (CIMA)

Fuente de la información: AEMPS (CIMA).

Licence: AEMPS open data reuse with attribution

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

HALMED — Agencija za lijekove i medicinske proizvode RH

HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.

Licence: Otvorena dozvola RH

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim

ALIMS

ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.

Licence: Serbian Open Data Licence (sodl)

All 7 sources

Health Sciences Authority / data.gov.sg

Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence

Licence: Singapore Open Data Licence

Report an error or request removalCorrections from the company itself are welcome.

Labiana Pharmaceuticals S.L.U

Medicines

Countries

Know your medicines, with the sources.

Therapeutic areas

Top substances

Names in the registers

Sources and licences

At a glance

Spain: more companies